Supplementary Figure 4 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Wei Liu,Kristine Glunde,Zaver M. Bhujwalla,Venu Raman,Anit Sharma,James M. Phang

DOI: https://doi.org/10.1158/0008-5472.22393179.v1

2023-01-01

Abstract:PDF file - 77K, Western blot confirms the knockdown of POX by siRNA in HT29 cells

What problem does this paper attempt to address?

Supplementary Figure 5 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Wei Liu,Kristine Glunde,Zaver M. Bhujwalla,Venu Raman,Anit Sharma,James M. Phang

DOI: https://doi.org/10.1158/0008-5472.22393176

2023-01-01

Abstract:PDF file - 282K, Upregulation of POX does not induce apoptosis under hypoxia
Supplementary Figure 1 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Wei Liu,Kristine Glunde,Zaver M. Bhujwalla,Venu Raman,Anit Sharma,James M. Phang

DOI: https://doi.org/10.1158/0008-5472.22393188

2023-01-01

Abstract:PDF file - 191K, Hypoxia upregulates POX expression in TK10 and Hs-578-T cell lines through AMPK activation
Supplementary Figure 3 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Wei Liu,Kristine Glunde,Zaver M. Bhujwalla,Venu Raman,Anit Sharma,James M. Phang

DOI: https://doi.org/10.1158/0008-5472.22393182

2023-01-01

Abstract:PDF file - 205K, Hypoxia-induced POX expression is independent of HIF-1alpha and HIF-2alpha
Supplementary Figure 2 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Wei Liu,Kristine Glunde,Zaver M. Bhujwalla,Venu Raman,Anit Sharma,James M. Phang

DOI: https://doi.org/10.1158/0008-5472.22393185

2023-01-01

Abstract:PDF file - 48K, POX mRNA increases in MDA-MB-231 HRE-EGFP breast cancer cells exposed to hypoxia
Data from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Wei Liu,Kristine Glunde,Zaver M. Bhujwalla,Venu Raman,Anit Sharma,James M. Phang

DOI: https://doi.org/10.1158/0008-5472.c.6503706

2023-01-01

Abstract:AbstractProline is a readily released stress substrate that can be metabolized by proline oxidase (POX) to generate either reactive oxygen species (ROS) to induce apoptosis or autophagy or ATP during times of nutrient stress. However, the contribution of proline metabolism to tumorigenesis in hypoxic microenvironments has not been explored. In this study, we investigated the different functions of POX under hypoxia and glucose depletion. We found that hypoxia induced POX expression in cancer cells in vitro and that POX upregulation colocalized with hypoxic tissues in vivo. In addition, the combination of hypoxia and low glucose showed additive effects on POX expression. Similar to conditions of low glucose, hypoxia-mediated POX induction was dependent on AMP-activated protein kinase activation but was independent of HIF-1α and HIF-2α. Under low-glucose and combined low-glucose and hypoxic conditions, proline catabolized by POX was used preferentially for ATP production, whereas under hypoxia, POX mediated autophagic signaling for survival by generating ROS. Although the specific mechanism was different for hypoxia and glucose deprivation, POX consistently contributed to tumor cell survival under these conditions. Together, our findings offer new insights into the metabolic reprogramming of tumor cells present within a hostile microenvironment and suggest that proline metabolism is a potential target for cancer therapeutics. Cancer Res; 72(14); 3677–86. ©2012 AACR.
Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528440.v1

2023-01-01

Abstract:PDF file, 125K, Western blot of total PARP1.
Abstract 2067: Tumor cell survival under microenvironmental stress: Hypoxia and/or low glucose upregulate poline oxidase

james m phang,anit sharma,wei liu

DOI: https://doi.org/10.1158/1538-7445.am2011-2067

IF: 11.2

2014-01-01

Cancer Research

Abstract:Proline is a stress substrate which can be readily released from collagen in extracelluar matrix (ECM) initiated by matrix metalloproteinases accompanying tumor progression and invasion. Proline oxidase (POX) can metabolize proline to generate reactive oxygen species (ROS) for inducing apoptosis or autophagy; it also is a source of energy (ATP) under metabolic stress. However, the contribution of proline metabolism to tumorigenesis under concurrent hypoxia and low-glucose in the tumor microenvironment, has not been explored. In the present study, we showed that hypoxia and low glucose induced POX expression in HT29 colorectal cancer cells. The combination of low-glucose and hypoxia had additive effects on POX expression. Knockdown of HIF-1α, an important mediator of the hypoxic response, did not alter POX expression. Instead, inhibition of the activation of AMPK, the celluar energy sensor, by its antagonist (Compound C) blocked the upregulation of POX under conditions of either hypoxia or low glucose. Functional studies showed POX was consistently responsible for the maintenance of cell growth under hypoxia, low-glucose or with the combination of both. However, ATP and ROS assays showed that ATP production from POX was favored under low-glucose condition with or without hypoxia, whereas POX preferred ROS production with hypoxia. POX knockdown partially decreased hypoxia-induced prosurvival autophagy, which was also decreased by the antioxidant, N-acetylcysteine. Taken together, these results suggest that the induction of proline metabolism with hypoxia and/or low-glucose contributes an important mechanism by which tumor cells switch to a survival mode. These findings offer new insights into our understanding of energy metabolism in tumor cells beyond the well-recognized Warburg effect of aerobic glycolysis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2067. doi:10.1158/1538-7445.AM2011-2067
Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John S. Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen K. Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528434.v1

2023-01-01

Abstract:<p>PDF file, 81K, Effect of PARP inhibition in combination with standard chemotherapy.</p>
Proline Metabolism and Cancer

James M. Phang,Wei Liu

DOI: https://doi.org/10.2741/4022

2012-01-01

Frontiers in Bioscience

Abstract:Proline plays a special role in cancer metabolism. Proline oxidase (POX), a.k.a. proline dehydrogenase (PRODH), is among a few genes induced rapidly and robustly by P53, the tumor suppressor. Ectopic expression of POX under control of tet-off promoter initiated mitochondrial apoptosis. The mechanism activated by POX is mediated by its production of ROS. In immunodeficient mice, POX overexpression markedly retarded growth of xenograft tumors. In human tumors of the digestive tract and kidney, POX was markedly decreased, suggesting that the suppressive effect of POX was downregulated. This was not due to POX gene mutations or hypermethylation. Instead, a microRNA, miR-23b*, expressed at high levels in tumors, was a potent inhibitor of POX expression. Furthermore, antagomirs of miR-23b* reversed the downregulated expression of POX and its tumor-suppressive effect, thereby providing a therapeutic strategy. POX not only responds to genotoxic stress, but also to inflammatory and metabolic stress. Depending on microenvironmental and temporal factors, POX can mediate oppositely-directed responses-programmed cell death, on the one hand, and survival, on the other.
Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507974.v1

2023-01-01

Abstract:Nuclear p53 plays a critical role in synergistic cytotoxic effect in RKO cells.
Supplementary Figures 1 - 5 from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

Aifu Lin,Hai-long Piao,Li Zhuang,Dos D. Sarbassov,Li Ma,Boyi Gan

DOI: https://doi.org/10.1158/0008-5472.22401407

2023-01-01

Abstract:PDF file - 232KB, Figure S1: FoxO subcellular localization under NVP-BEZ235, BKM120, or MK-2206 treatment. Figure S2: Quantified ratios of AKT phosphorylation levels to total AKT levels in FoxO WT and KO cells after 50 nM NVP-BEZ235 treatment. Figure S3: The effect of high dosage NVP-BEZ235 on cell proliferation in FoxO WT and KO cells. Figure S4: Rictor knockdown potentiates cell proliferation suppression and cell death induction in response to NVP-BEZ235 treatment in RCC cells. Figure S5: The expression levels of p27 and Bim in FoxO deficient cells under NVPBEZ235 treatment.
Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Amanda Herzog,Yansong Bian,Robert Vander Broek,Bradford Hall,Jamie Coupar,Hui Cheng,Anastasia L. Sowers,John D. Cook,James B. Mitchell,Zhong Chen,Ashok B. Kulkarni,Carter Van Waes

DOI: https://doi.org/10.1158/1078-0432.22445265

2023-01-01

Abstract:PDF file - 1957K, Treatment in UM-SCC xenograft and Tgfbr1/Pten KO mice.
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

Zhen–Bin Ding,Bo Hui,Ying‐Hong Shi,Jing Zhou,Yuan‐Fei Peng,Chengyu Gu,Hua Ye,Guo‐Ming Shi,Ai‐Wu Ke,Xiaoying Wang,Kun Song,Zhi Dai,Yongchun Shen,Jia Fan

DOI: https://doi.org/10.1158/1078-0432.22443171.v1

2023-01-01

Abstract:PDF file - 594K, Analysis of transfection efficiency by fluorescent microscopy.
Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth Through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Haiyan Qin,Dimitrios Iliopoulos,Tatsuya Nakamura,Stefan Costinean,Stefano Volinia,Teresa Druck,Jun Sun,Hiroshi Okumura,Kay Huebner

DOI: https://doi.org/10.1158/1541-7786.22521039

2023-01-01

Abstract:Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Figure 4 from Tirapazamine Sensitizes Hepatocellular Carcinoma Cells to Topoisomerase I Inhibitors Via Cooperative Modulation of Hypoxia-Inducible Factor-1α

Tian-Yu Cai,Xiao-Wen Liu,Hong Zhu,Ji Cao,Jun Zhang,Ling Ding,Jian-Shu Lou,Qiao-Jun He,Bo Yang

DOI: https://doi.org/10.1158/1535-7163.22500619

2023-01-01

Abstract:PDF file - 131K, Figure S4. TPZ and SN-38 decrease the rate of HIF-1alpha protein synthesis.
Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment.

Wei Liu,James M Phang

DOI: https://doi.org/10.4161/auto.21152

IF: 13.391

2012-01-01

Autophagy

Abstract:Proline dehydrogenase (oxidase, PRODH/POX), the first enzyme in the pathway of proline catabolism, has been identified as a mitochondrial, metabolic tumor suppressor, which is downregulated in a variety of human tumors. However, our recent findings show that PRODH/POX is upregulated by hypoxia in vitro and in vivo. The combination of low glucose and hypoxia produces additive effects on PRODH/POX expression. Both hypoxia and glucose depletion enhance PRODH/POX expression through AMP-activated protein kinase (AMPK) activation to promote tumor cell survival. Nevertheless, the mechanisms underlying PRODH/POX prosurvival functions are different for hypoxia and low-glucose conditions. Glucose depletion with or without hypoxia elevates PRODH/POX and proline utilization to supply ATP for cellular energy needs. Interestingly, under hypoxia PRODH/POX induces protective autophagy by generating reactive oxygen species (ROS). AMPK is the main initiator of stress-triggered autophagy. Thus, PRODH/POX acts as a downstream effector of AMPK in the activation of autophagy under hypoxia. This regulation was confirmed to be independent of the mechanistic target of rapamycin (MTOR) pathway, a major downstream target of AMPK signaling.
Supplementary Figure S1 from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Yong Li,Shunqun Luo,Ruihua Ma,Jing Liu,Pingwei Xu,Huafeng Zhang,Ke Tang,Jingwei Ma,Yi Zhang,Xiaoyu Liang,Yanling Sun,Tiantian Ji,Ning Wang,Bo Huang

DOI: https://doi.org/10.1158/0008-5472.22410017.v1

2023-01-01

Abstract:Supplementary Figure S1. The silence efficiency of siRNA against G9a, SUV39h1 or PCK1 and identification of constructs.
Figure S11 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602167

2024-01-01

Abstract:Figure S11. Semiquantitative statistical analysis of percentages of specific areas affected by pimonidazole based on the fluorescence images in Figure 4I. (***p < 0.001, **p < 0.01).

Supplementary Figure 4 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Supplementary Figure 5 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Supplementary Figure 1 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Supplementary Figure 3 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Supplementary Figure 2 from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Data from Proline Oxidase Promotes Tumor Cell Survival in Hypoxic Tumor Microenvironments

Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Abstract 2067: Tumor cell survival under microenvironmental stress: Hypoxia and/or low glucose upregulate poline oxidase

Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Proline Metabolism and Cancer

Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figures 1 - 5 from FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway

Supplementary Figure 5 from PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth Through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 4 from Tirapazamine Sensitizes Hepatocellular Carcinoma Cells to Topoisomerase I Inhibitors Via Cooperative Modulation of Hypoxia-Inducible Factor-1α

Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment.

Supplementary Figure S1 from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Figure S11 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers